Webinar: Modernizing Your Transplant Program with an Integrated EVLP Service
Thursday, 1 June | 1:00 – 2:00 p.m. EDT / 17:00 – 18:00 UTC
Join ISHLT and Lung Bioengineering (LBE) for a one-hour webinar where an experienced LBE partner transplant center will provide a first-hand account of how their program has grown through utilization of EVLP services.
Matthew Bacchetta, MD will discuss how partnering with LBE for EVLP services has influenced the practices and mindset of the Vanderbilt University Medical Center lung transplant program over time. This program will be of interest to any clinician at a lung transplant center.
Visit the ISHLTv website for more information or to register, and watch this space for full program details. This webinar is free, but registration is required. The recording will be distributed to all attendees, so you can watch it even if you can’t attend live.
ABOUT THE SPEAKER
Matthew Bacchetta, MD is a lung transplant surgeon and NIH-funded researcher at Vanderbilt University Medical Center whose clinical work focuses on end-stage lung and pulmonary vascular diseases.
Dr. Bacchetta is one of the world’s most experienced clinicians in the use of mechanical devices for patients with acute and chronic respiratory illnesses. His research involves developing platforms for organ recovery, regeneration, and replacement.
He is an ISHLT member and Fellow of the American Institute for Medical and Biological Engineering. Prior to moving to Vanderbilt, he was an Associate Professor at Columbia University and worked as the Director of Adult ECMO and Surgical Director of the Pulmonary Hypertension Comprehensive Care Center, and Director of the Pulmonary Thromboendarterectomy Program. He has served in Iraq and Afghanistan in the US Army.
ABOUT LUNG BIOENGINEERING (LBE)
Lung Bioengineering Inc. (LBE) has established the first centralized ex vivo lung perfusion service model in the United States. LBE’s service model is driven by data and powered by the expertise of our clinical teams. Our model simplifies the journey from allocation to transplant, with a goal of expanding the utilization of transplantable lungs. Our team of specialists is available 24/7 to unify key touchpoints throughout each case to provide a seamless clinical experience and deliver results for our partners.